Wave Life Sciences Ltd.
OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF

Last updated:

Abstract:

Among other things, the present disclosure provides C9orf72 oligonucleotides, compositions, and methods thereof. In some embodiments, the present disclosure provides methods for treating C9orf72-associated conditions, disorders or diseases, such as amyotrophic lateral sclerosis and frontotemporal dementia.

Status:
Application
Type:

Utility

Filling date:

8 May 2020

Issue date:

12 May 2022